Albert
H. Capanna, M.D., Joseph LaMancusa, Jr., M.D., Franco Erculei, M.D.,
Professor Kazem Fathie, M.D., Peter Christenson, M.D., and David A.
Mulkey, M.D.
Division of Neurosurgery (AHCFE, KF), Department
of Radiology (PC), and Department of Pathology (DAM), The University
of Nevada School of Medicine, Las Vegas, Nevada, and Department of
Psychiatry (JL), Presbyterian Medical Center, San Francisco, California
Two consortial
partners presented within 3 weeks of one another with signs and symptoms
of neurological dysfunction. Both were found to have acquired immune
deficiency syndrome (AIDS) and primary cerebral lymphoma. We found
17 case reports of primary central nervous §ystem (CNS) lymphoma in
AIDS patients. Ten of these cases were described sufficiently to enable
analysis. Our 2 cases are unique in that this is the first time primary
CNS lymphoma has been reported in sexual partners with AIDS. One case
includes the use of magnetic resonance imaging. Both patients underwent
craniotomy and received radiation therapy. (Neurosurgery 21:920-923,
1987)
Introduction
ThAcquired immune deficiency syndrome (AIDS) is a disease initially
described in 1981 (1). AIDS is characterized by defects in the immune
system of an individual who is infected with the human immunodeficiency
virus (HIV). Clinically, AIDS patients frequently present initially
with Kaposi's sarcoma, Pneumocystis carinii pneumonia, cytomegalovirus
infection, and other opportunistic infections. The causative virus
is transmitted through sexual activity, exposure to infected body
fluids, and blood transfusions. The disease has been seen most frequently
in homosexual men, intravenous drug users, Hai- tians, and hemophiliacs.
HIV, a retrovirus, selectively infects and destroys T4 lymphocytes,
leading to an apparently per- manent immunodeficiency. Neurological
symptoms are present in 39% of all AIDS patients; in one-third of
these, nervous system involvement is responsible for the chief complaint
(8). The first case of primary brain lymphoma in an AIDS patient was
described in 1983 (12). There have been a total of 17 reported cases
confirmed by brain biopsy and/or postmortem findings (6, 7, 9-13).
Sufficient information is available from 10 of these cases to allow
important findings to be summarized.
CASE REPORTS
Case I A 46-year-old, homosexual man was admitted to University Medical
Center in Las Vegas, Nevada, on February 11, 1986, with a 3-week history
of generalized seizures of recent onset, decreased level of consciousness,
and complaints of slurred speech and dizziness. He was taking phenytoin,
100 mg 3 times daily. He had had oral thrush for the preceding 7 months,
an unspecified parasitic infection in May 1985, hep- atitis in June
1985, and syphilis in 1962. Physical examination on admission revealed
bilateral an- terior and posterior cervical adenopathy. The vital
signs, including temperature, were normal. Examination of the heart,
lungs, abdomen, and nervous system were within nor- mal limits. Laboratory
studies on admission were significant for a depressed white blood
cell count of 2.3 x 10' (normal, 4-12 x 109). The electrolytes, hemoglobin
and platelet counts, liver function, and kidney function were within
normal limits. The phenytoin level was within the therapeutic range.
A chest x-ray film was normal. On admission, computed tomography (CT)
showed a 3.2- cm enhancing ring in the right frontal lobe with two
small enhancing satellite rings and mild edema. There was no midline
shift, and the findings were interpreted as being most compatible
with cerebral abscess. The patient was placed on intravenous antibiotics
and followed with weekly CT, which showed no significant change (Figs.
I and 2). Angiography was consistent with an inflam- matory process
involving the right frontal lobe. Further lab- oratory investigation
revealed a T cell helper/suppressor ratio of 0.3 (normal, I to 3)
and antibodies to HIV. On February 28, 1986, the patient underwent
a right fron- toparietal craniotomy for excision of the lesions. The
histo- logical diagnosis was immunoblastic malignant lymphoma (Fig.
3). Postoperatively, the patient did well, was started on radiotherapy,
and was discharged on March 3, 1986. Case 2 A 32-year-old, homosexual
man, whose sexual partner is patient 1, was admitted to the University
Medical Center of Southern Nevada on March 4, 1986, with complaints
of a 3-month history of intermittent fever, night chills, and malaise
that had not improved with outpatient treatment. He had a 3-month
history of an ataxic gait and increasing difficulty with writing.
He was taking Bactrim DS (sulfamethoxazole- trimethoprim; Roche Laboratories,
Nutley, New Jersey), one tablet twice daily. His medical history included
hepatitis in 1980, glomen@do- nephritis in 1972, and rheumatic fever
in 1960. The patient had normal vital signs. Neurological examina-
tion revealed left dysmetria, a mildly ataxic gait, and a positive
Romberg's sign. Cranial nerve function, the deep tendon reflexes,
sensation, and motor strength were within normal limits. Examinations
of the heart, lungs, abdomen, and ex- tremities were essentially unremarkable.
Abnormal laboratory studies consisted of a low platelet count (79
x 10'/Iitre; normal, 150 to 375), HIV antibody positivity, and cytomeg-
alovirus titer of 1:6400. A chest x-ray film was normal. CT on admission
demonstrated a high, right parietal lesion (Fig. 4), consistent with
an abscess or region of cerebritis, and the patient was placed on
antibiotics. A magnetic resonance imag@ng (MRI) examination clearly
delineated the extent of the lesion (Figs. 5 and 6). On March 15,
1986, a right pariew craniotomy was per- formed. The pathological
diagnosis was immunoblastic lym- phoma, with a pattern similar to
that in Case 1. In both cases, the cells reacted to antibodies to
panlymphoid antigen and were negative for glial fibriuary acidic protein,
confirming their lymphoid origin (Fig. 7). Postoperatively, the patient
did well and was started on radiation therapy. He was discharged on
March 21, 1986.
fig. 1. Case 1. Aright frontal lobe, fig.
2. Case 1. Sixteen days later, enhanced
3.2-cm lesion with a contrast- CT
shows three lesions. The small,
enhanced margin is surrounded intervenin
lesion may have developed
by low density, white matter or
may have been below the level of the
edema. The initial CT appearance previous
scans. The edema is unchanged.
is nonspecific, compatible with Lack
of response to antibiotics prompted a
either cortical abscess or tumor. request
for surgical biopsy.
fig. 3. Case 1. Malignant lymphoma. A, small cerebral blood vessels
show perivasculr infiltration of lymphocytes (x10). B, large lymphocytess
with prominent nucleoli are characteristic of immunoblasts(x40).

fig 4. Case 2: On enhanced CT, a small fig.
5. Case 2: On MRI, T2-weighted image, the
region of low density with margin en- lesion
shows high signal intensity.
hancement is present in the upper,
parasagital, right parietal cortex. This
was originally interpreted as a zone of
cerebritis or possibly subacute ischemic
infarction.
fig 6. Case 2: On a coronal-oriented MRI scan, a T2-weighted
image
confirms the parasagittal, right parietal location of the high
signal
intensity lesion extending deep into the adjacent parietal
white
matter. The curvilinear line of high intensity in the left parietal
area
is cerebrospinal fluid in a posterior parietal sulcus. The some-
what
rectangular, high intensity region below it is the posterior end
of
the left occipital horn.
DISCUSSION
These two cases are unique among the reported cases of primary central
nervous system (CNS) lymphoma in patients with AIDS: (a) primary CNS
lymphoma has never been documented in sexual partners with AIDS, (b)
the diagnosis of primary CNS lymphoma has not included MRI data, and
(c) primary CNS lymphoma in patients with AIDS has not been treated
with both open surgical excision and radiation therapy. Approximately
2% of all malignant lymphomas are confined to the CNS (3). ). Non-Hodgkin's
fig.
7. Case 2: The cleared nuclear chromatin and prominent
nucleoli
are typical of activated or transformed lymphocytes,
or
immunoblasts(x40).
lymphomas account for 3% of all tumors in the general
population (4). The patient with AIDS apparently has a significantly
increased chance of developing non-Hodgkin's lymphoma. Already there
are reports in the literature of 17 cases of primary CNS lymphoma
in these immunocompromised patients. The reasons for this increased
incidence is unknown, but several hypotheses have been promulgated
in the literature (4, 5, 14). Our report of two sexual partners with
CNS lymphoma suggests a transmittable causative factor. Abnormal CT
is present in 27% of patients with AIDS who develop neurological symptoms
(2). The most common abnormalities are toxoplasmosis, progressive
multifocal leukoencephalopathy, lymphoma, and hemorrhage. In many
in- stances, the CT findings are nonspecific and tissue biopsy is
necessary for definitive diagnosis. On CT examination, lymphomas often
demonstrate meningeal enhancement and nodular or ring-enhancing lesions
in the deep, periventricular white matter and may well be confused
with an infectious process (2). There is little reported experience
using MRI for the diagnosis of primary CNS lymphomas, and its utility
as the primary diagnostic tool is unknown. Comparison of the CT and
MRI in our second patient, however, suggests that MRI may be more
sensitive. Of the primary CNS lymphomas reported in AIDS patients,
50% are of the immunoblastic type. Radiation has been the treatment
of choice for primary CNS lymphoma in patients both with and without
AIDS. The average survival after radiation treatment in non-AIDS patients
is 15.2 months (3), whereas the longest survival in an AIDS patient
was 9 months. The survival after both operation and radiation is not
known for the AIDS group. In both of our cases, radiation treatment
followed surgical excision. Even though AIDS is ultimately fatal,
it is hoped that combined therapy may prolong the survival of AIDS
patients with cerebral lymphoma. CNS lesions in patients with AIDS
are diverse, and our two cases underscore the need for precise histopathological
diagnosis in each case to ensure institution of the most appropriate
treatment.
ACKNOWLEDGMENTS We thank Dawn M. Capanna, R.N., B.S.,
Kathy Conrad, and Penni Gordhamer.
REFERENCES
1. Centers for Disease Control: Revision of the case definition of
acquired immunodeficiency syndrome for national reporting- United
States. MMWR 34:373-375,1985.
2. Elldn CM, Leon E, Grenell SL, Leeds NE: Intracranial lesions in
the acquired immunodeficiency syndrome. JAMA 253:393-396, 1985.
3. Henry JR, Hefner RR, Dillard SH, Earle KM, Davis RL: Primary malignant
lymphomas of the central nervous system. Cancer 34:1293-1302, 1974.
4. Joachim HL, Cooper MC, Hellman CirC: Lymphomas in men at high risk
for acquired immune deficiency syndrome (AIDS): A study of 21 cases.
Cancer 56:2831-2842, 1985.
5. Kay HE: lmmunosuppression and the risk of lymphoma. N Engl J Med
308:1099-1100,1983 (letter).
6. Kelly WM, Brant-Zawadkki M: Acquired immunodeficiency syndrome:
Neuroradiologic findings. Radiology 149:485-491, 1983.
7. Lehrick JR, Hedley-White ET, Harris NL: Acquired immuno- deficiency
syndrome and cranial nerve abnormalities. N Engi J Med 309:359-369,
1983.
8. Levy RM, Bredesen DE, Rosenblum ML: Neurological manifes- tations
of the acquired immunodeficiency syndrome (AIDS): Experience at UCSF
and review of the literature. J Neurosurg 62:475-495, 1985.
9. Levy RM, Pons VG, Rosenblum ML: Central nervous system mass lesions
in the acquired immunodeficiency syndrome (AIDS). J Neurosurg 61:9-16,1984.
10. Reyes CV: Primary malignant lymphonia of the brain in acquired
immune deficiency syndrome. Acta Cytol (Baltimore) 29:85-86, 1985
(letter).
11. Shiach CR, Burt AD, Isles CG, Ball SG: Pyrexia of undetermined
origin, diarrhea, and primary cerebral lymphoma associated with acquired
immunodeficiency. Br Med J 288:449-450,1984.
12. Snider V,/D, Simpson DM, Dronyk KE: Primary lymphoma of the nervous
system associated with acquired immune-deficiency syndrome. N Engi
J Med 308:45,1983 (letter).
13. Whalen MA, Kricheff 11, Handler M, Ho V, Crystal K, Gopinathan
G, Laubenstein L: Acquired immunodeficiency syndrome: Cerebral computed
tomographic manifestations. Radiology 149:477-484, 1983.
14. Ziegler JL, Beckstead JA, Volberding PA, Abrams DI, Levine AM,
Lukes RJ, Gill PS, Burkes RL, Meyer PR, Metroka CE, Mouradian J, Moore
A, Riggs SA, Butler JJ, Cabanillas FC, Hersh E, Newell GR, Laubenstein
LJ, Knowles D, Odajnyk C, Raphael B, Koziner B, Urmacher C, Clarkson
BD: Non-Hodg- kin's lymphoma in 90 homosexual men: Relation to generalized
lymphadenopathy and the acquired immunodeficiency syndrome. N Engl
J Med 311:565-570,1984.
COMMENT
This is a very interesting report of two patients, both of whom have
AIDS and who developed the fairly rare entity of primary brain lymphoma.
It should serve to remind all of us who are asked to care for these
patients that ring-enhancing lesions are not necessarily an infectious
process and that the immune system does seem to play a role in the
control of neoplastic disease. It also allows one to hypothesize that
perhaps some, if not all, neoplastic disease is infectious in origin.
As devastating as the AIDS epidemic is, medical science may yet learn
a great deal about other disease processes as a result of the immunodeficiency
caused by the HTLV-3 virus.
Frances Conley
Stanford, CA